Q2 2016

Filed Aug 5, 2016 · 10-Q · 36 days after period end · 0000877860-16-000144

Q2 2016 · 10-Q

Revenue

$61.20M

+8.7% vs Q2 2015

Net Income

$44.60M

+43.0% vs Q2 2015

EPS Diluted

$1.16

+39.8% vs Q2 2015

Operating Income$18,600,000—

Operating Cash Flow

Same quarter

Metric	Q2 2016	Q2 2015	Q2 2014	Q2 2013
Revenue	$61.20M	$56.31M	$44.16M	$27.09M
Net Income	$44.60M	$31.18M	$25.29M	$19.92M
EPS Diluted	$1.16	$0.83	$0.76	$0.71

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR